Home » Stocks » SMLR

Semler Scientific Inc. (SMLR)

Stock Price: $88.68 USD 6.68 (8.14%)
Updated Jan 15, 2021 3:57 PM EST - Market closed
Market Cap 590.42M
Revenue (ttm) 35.68M
Net Income (ttm) 11.45M
Shares Out 6.58M
EPS (ttm) 1.44
PE Ratio 61.80
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $88.68
Previous Close $82.00
Change ($) 6.68
Change (%) 8.14%
Day's Open 82.15
Day's Range 82.15 - 89.73
Day's Volume 8,083
52-Week Range 30 - 95

News

Hide News
  • All
  • Videos
  • Press Releases
PRNewsWire - 1 week ago

SANTA CLARA, Calif., Jan. 7, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of he...

Seeking Alpha - 2 weeks ago

The pandemic blip seems all but a distant memory for the company even if not all of the risk has cleared. The company just keeps growing and producing awe-inspiring margins, it doesn't happen ...

Zacks Investment Research - 2 months ago

Top Ranked Momentum Stocks to Buy for November 17th

Other stocks mentioned: CTHR, FLGT, RM
Zacks Investment Research - 2 months ago

Top Ranked Momentum Stocks to Buy for November 12th

Other stocks mentioned: GM, HOG, PRSC
PRNewsWire - 2 months ago

SANTA CLARA, Calif., Nov. 12, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of h...

Seeking Alpha - 2 months ago

Semler Scientific, Inc. (SMLR) CEO Doug Murphy-Chutorian on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 258.82% and 24.44%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead f...

Zacks Investment Research - 2 months ago

Semler Scientific Inc. (SMLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Motley Fool - 2 months ago

Discover how these three companies could change the face of healthcare.

Other stocks mentioned: DMTK, TRUP
Seeking Alpha - 3 months ago

While the company has experienced headwinds from the pandemic, growth is already returning.

Zacks Investment Research - 3 months ago

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: FMS
Zacks Investment Research - 4 months ago

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: FMS
The Motley Fool - 4 months ago

No matter what the month, stay the course.

Other stocks mentioned: AMZN, CHWY, PTON, SHOP
PRNewsWire - 5 months ago

SAN JOSE, Calif., Aug. 17, 2020 /PRNewswire/ -- Semler Scientific, Inc.

Zacks Investment Research - 5 months ago

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: FMS
Seeking Alpha - 5 months ago

Semler Scientific's (SMLR) CEO Doug Murphy-Chutorian on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of 116.67% and -15.48%, respectively, for the quarter ended June 2020.

The Motley Fool - 5 months ago

All three offer innovative technology that meets major healthcare needs.

Other stocks mentioned: GH, LVGO
Seeking Alpha - 5 months ago

3 Potentially Undervalued Small-Cap Ideas

Other stocks mentioned: XPEL
The Motley Fool - 5 months ago

There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.

Other stocks mentioned: IDXX, ZYXI
Zacks Investment Research - 5 months ago

Semler Scientific (SMLR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

The Motley Fool - 6 months ago

I'm putting real money behind these hidden healthcare winners.

Other stocks mentioned: NVCR
Seeking Alpha - 7 months ago

Semler Scientific is a high growth company with annual sales increasing at a CAGR of 37% since 2015.

Seeking Alpha - 7 months ago

The company has simplified the testing of PAD, which is a marker for increased risk of stroke and cardiovascular disease.

Seeking Alpha - 7 months ago

Semler Scientific: High-Quality Medical Stock With Cash Flow Growth And Zero Debt

Seeking Alpha - 8 months ago

Semler Scientific, Inc. (SMLR) CEO Doug Murphy-Chutorian on Q1 2020 Results - Earnings Call Transcript

The Motley Fool - 9 months ago

It's time to get greedy with these beaten-down businesses.

Other stocks mentioned: HQY, PINS
Seeking Alpha - 10 months ago

Semler Scientific, Inc. (SMLR) CEO Doug Murphy-Chutorian on Q4 2019 Results - Earnings Call Transcript

The Motley Fool - 10 months ago

These three companies are all growing like gangbusters and have already reached profitability.

Other stocks mentioned: BYND, FLGT
The Motley Fool - 11 months ago

We take a look at three small and promising healthcare companies across diagnostics, surgical products, and genetic testing.

Other stocks mentioned: FLGT, LMAT

About SMLR

Semler Scientific develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans... [Read more...]

Industry
Medical Devices
IPO Date
Feb 21, 2014
CEO
Douglas Murphy-Chutorian
Employees
67
Stock Exchange
OTCMKTS
Ticker Symbol
SMLR
Full Company Profile

Financial Performance

In 2019, SMLR's revenue was $32.77 million, an increase of 52.47% compared to the previous year's $21.49 million. Earnings were $15.08 million, an increase of 200.84%.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for SMLR is 94.67, which is an increase of 6.76% from the latest price.

Price Target
$94.67
(6.76% upside)